Wiebe, Ellen, M.D.
Quick facts
Marketed products
- methotrexate + misoprostol · Oncology; Rheumatology
Methotrexate inhibits dihydrofolate reductase to suppress cell proliferation, while misoprostol protects the gastrointestinal mucosa from methotrexate-induced damage.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: